Literature DB >> 15008846

Maintaining glycaemic control during high-dose prednisolone administration for hyperemesis gravidarum in Type 1 diabetes.

U K Dashora, R Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15008846     DOI： 10.1046/j.1464-5491.2003.01026_21_3.x-i1

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  5 in total

1.  Termination is not the treatment of choice for severe hyperemesis gravidarum: Successful management using prednisolone.

Authors:  E Al-Ozairi; J J S Waugh; R Taylor
Journal:  Obstet Med       Date:  2009-03-01

2.  Management of Glucocorticoid-Induced Hyperglycemia.

Authors:  Parag Shah; Sanjay Kalra; Yogesh Yadav; Nilakshi Deka; Tejal Lathia; Jubbin Jagan Jacob; Sunil Kumar Kota; Saptrishi Bhattacharya; Sharvil S Gadve; K A V Subramanium; Joe George; Vageesh Iyer; Sujit Chandratreya; Pankaj Kumar Aggrawal; Shailendra Kumar Singh; Ameya Joshi; Chitra Selvan; Gagan Priya; Atul Dhingra; Sambit Das
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-23       Impact factor: 3.249

3.  COVID-19 and dexamethasone-induced hyperglycaemia: Workload implications for diabetes inpatient teams.

Authors:  Younes R Younes; Susan Stockley; Lorna Keegan; Linda O'Donoghue; Elizabeth Yohannan; Liz Read; Jamie-Leigh Williamson; John Peter; Kavitha Lakshmipathy; Vera Smout; Vidhu Nayyar; Julian Emmanuel; Sunil Zachariah; James Clark; Benjamin C T Field
Journal:  Diabet Med       Date:  2021-10-22       Impact factor: 4.213

Review 4.  A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital.

Authors:  Felix Aberer; Daniel A Hochfellner; Harald Sourij; Julia K Mader
Journal:  J Clin Med       Date:  2021-05-16       Impact factor: 4.241

5.  Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.

Authors:  G Rayman; A N Lumb; B Kennon; C Cottrell; D Nagi; E Page; D Voigt; H C Courtney; H Atkins; K Higgins; J Platts; K Dhatariya; M Patel; P Newland-Jones; P Narendran; P Kar; O Burr; S Thomas; R Stewart
Journal:  Diabet Med       Date:  2020-09-21       Impact factor: 4.213
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.